Table 5.
The top 10 most co-cited references related to curcumin.
| Author | Citations | Title | Journal | Year |
|---|---|---|---|---|
| Kunnumakkara AB | 57 | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Cancer Lett | 2008 |
| Preetha Anand | 52 | Bioavailability of curcumin: problems and promises | Mol Pharm | 2007 |
| Goel A | 48 | Curcumin as “Curecumin”: from kitchen to clinic | Biochem Pharmacol | 2008 |
| Ornchuma Naksuriya | 44 | Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment | Biomaterials | 2014 |
| Nelson KM | 44 | The Essential Medicinal Chemistry of Curcumin | J Med Chem | 2017 |
| Anand P | 43 | Curcumin and cancer: an “old-age” disease with an “age-old” solution | Cancer Lett | 2008 |
| Yallapu MM | 42 | Curcumin nanoformulations: a future nanomedicine for cancer | Drug Discov Today | 2012 |
| Navneet Dhillon | 40 | Phase II trial of curcumin in patients with advanced pancreatic cancer | Clin Cancer Res | 2008 |
| Gupta SC | 38 | Therapeutic roles of curcumin: lessons learned from clinical trials | AAPS J | 2013 |
| Aggarwal S | 37 | Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation | Mol Pharmacol | 2006 |